Pathways to safe medicines: protecting patients through unified global action

12 June, 2013

This conference will examine converging and interoperable solutions that strengthen international cooperation in combating the production and distribution of substandard/spurious/falsely labelled/falsified/counterfeit (SSFFC) drugs.

Pathways to safe medicines: protecting patients through unified global action

Wednesday 26 – Friday 28 June 2013 (WP1185)

As the assault on the global medicine cabinet intensifies, leading decision makers gather to discuss the critical public health/socio-economic development/trade nexus that impacts global access to safe medicines.  The dialogue will gather a uniquely diverse group of senior policy makers, pharmaceutical manufacturers, academics, and civil society health advocates.  The participants will examine breakthrough ideas intended to strengthen global collaboration in the face of the growing threat posed by falsified and substandard medicines.

Senior drug regulators from the United States and the UK will join counterparts from emerging markets in Africa, Asia, and South America, demonstrating the compelling need for national, regional, and international partnerships.  The most vulnerable consumers in the international pharmaceutical supply chain face the greatest challenge, as systems that protect drug access and quality frequently fail to keep pace with the inflow of dangerously fake or low quality medicines.  The dialog will also include experts familiar with innovative and proven technology that helps protect consumers in many countries.

From malaria drugs to cancer treatments, weekly international headlines raise public concern about the safety of the drugs consumed throughout the world and this discussion will explore the common ground needed to launch a truly global coalition for a pathway to safe medicines.

 

Further information

Conference on Pathways to safe medicines: protecting patients through unified global action

Stay up to date

Sign up to our newsletter